drug · antibody
patient view →navicixizumab
Phase 2updated 2mo agoby Feng Biosciences Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 1 (across all indications), with 6 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that